Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, pharmaceuticals, and health food products in Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, Canada, and Russia. The company's Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; and NOV hypoallergenic cosmetics, as well as...
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, overpriced
Target Price
The average target price of 4928.T is 4810 and suggests 4% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
Buy
Sell